Finance

Lists
Why is 301230 up 9.61%?
Dive Deeper
301230:SHE
PharmaResources (Shanghai) Co Ltd
CN¥30.79
+9.61%
(+2.70) 1D
Oct 28, 3:04:25 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301230...
Open
CN¥28.50
High
CN¥31.92
Low
CN¥28.02
Mkt. cap
5.36B
Avg. vol.
21.98M
Volume
24.01M
Dividend
0.92%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jul 16, 2026
P/E ratio
195.18
52-wk high
CN¥52.28
52-wk low
CN¥22.23
EPS
CN¥0.16
Shares outstanding
180.94M
No. of employees
1K
Open
CN¥28.50
High
CN¥31.92
Low
CN¥28.02
Mkt. cap
5.36B
Avg. vol.
21.98M
Volume
24.01M
Dividend
0.92%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jul 16, 2026
P/E ratio
195.18
52-wk high
CN¥52.28
52-wk low
CN¥22.23
EPS
CN¥0.16
Shares outstanding
180.94M
No. of employees
1K
News stories
From web sources and news partners
About PharmaResources (Shanghai) Co Ltd
CEO-
Employees1.3K
FoundedDec 14, 2007
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
173.95M
172.29M
192.12M
186.39M
Cost of goods sold
141.40M
117.29M
154.67M
130.54M
Cost of revenue
141.40M
117.29M
154.67M
130.54M
Research and development expenses
8.36M
10.74M
10.16M
12.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.02M
27.59M
28.57M
30.36M
Operating expense
41.00M
38.16M
41.06M
33.45M
Total operating expenses
182.40M
155.45M
195.73M
163.99M
Operating income
-8.45M
16.83M
-3.61M
22.40M
Other non operating income
-1.69M
-2.12M
2.05M
-16.04M
EBT including unusual items
-3.51M
25.98M
4.15M
-1.61M
EBT excluding unusual items
-11.07M
19.90M
-2.44M
24.11M
Income tax expense
-3.05M
2.21M
-800.39K
-1.93M
Effective tax rate
87.04%
8.49%
-19.29%
120.01%
Other operating expenses
306.17K
327.40K
312.57K
-7.61M
Net income
-454.81K
23.78M
4.95M
321.31K
Net profit margin
-0.26%
13.80%
2.58%
0.17%
Earnings per share
-
-
-
-
Interest and investment income
177.60K
7.10M
5.13M
13.52M
Interest expense
-1.98M
-1.91M
-1.77M
-
Net interest expenses
-1.80M
5.18M
3.35M
13.52M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.39M
23.90M
3.89M
29.47M
Gain or loss from assets sale
-41.52K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps